NMNAT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.404200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.179000E-01
Normal-vs-Stage2
5.643800E-01
Normal-vs-Stage3
2.063600E-01
Normal-vs-Stage4
8.194000E-01
Stage1-vs-Stage2
5.344400E-01
Stage1-vs-Stage3
2.094400E-01
Stage1-vs-Stage4
7.725400E-01
Stage2-vs-Stage3
1.425170E-01
Stage2-vs-Stage4
3.739800E-01
Stage3-vs-Stage4
1.298040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.350200E-01
Normal-vs-AfricanAmerican
9.347400E-01
Normal-vs-Asian
6.218000E-01
Caucasian-vs-AfricanAmerican
3.256200E-01
Caucasian-vs-Asian
8.983200E-01
AfricanAmerican-vs-Asian
4.753800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.827600E-01
Normal-vs-Female
6.200600E-01
Male-vs-Female
6.098400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.800200E-01
Normal-vs-Age(41-60Yrs)
7.989400E-01
Normal-vs-Age(61-80Yrs)
4.821000E-01
Normal-vs-Age(81-100Yrs)
2.533400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.093400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.643800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.986400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.150000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.212780E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.579800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.010000E-01
Normal-vs-Daily Drinker
2.173400E-01
Normal-vs-Weekly Drinker
5.086600E-01
Normal-vs-Occasional Drinker
7.702000E-01
Normal-vs-Social Drinker
8.480800E-01
Non Drinker-vs-Daily Drinker
8.158600E-01
Non Drinker-vs-Weekly Drinker
4.035200E-01
Non Drinker-vs-Occasional Drinker
7.736400E-02
Non Drinker-vs-Social Drinker
9.282400E-02
Daily Drinker-vs-Weekly Drinker
5.261600E-01
Daily Drinker-vs-Occasional Drinker
1.299610E-01
Daily Drinker-vs-Social Drinker
1.493190E-01
Weekly Drinker-vs-Occasional Drinker
5.021000E-01
Weekly Drinker-vs-Social Drinker
4.969200E-01
Occasional Drinker-vs-Social Drinker
9.181600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.664400E-01
Normal-vs-Grade 2
9.119800E-01
Normal-vs-Grade 3
8.817200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.921400E-01
Grade 1-vs-Grade 3
7.941600E-01
Grade 1-vs-Grade 4
8.664400E-01
Grade 2-vs-Grade 3
4.996800E-01
Grade 2-vs-Grade 4
9.119800E-01
Grade 3-vs-Grade 4
8.817200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.381800E-01
Normal-vs-NonDiabetic
4.663400E-01
Diabetic-vs-NonDiabetic
4.301800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.819800E-01
Normal-vs-NoPancreatitis
4.467000E-01
Pancreatitis-vs-NoPancreatitis
7.399400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.858800E-01
Normal-vs-N1
5.828800E-01
N0-vs-N1
6.413200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.921800E-01
Normal-vs-TP53-NonMutant
7.607800E-01
TP53-Mutant-vs-TP53-NonMutant
9.347000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
